We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
The Mosaic Company
MOS
$7.03B
| $796K | 0.01% |
15,910
-78,684
| -83% | -$3.75M |
|
502
FMC
FMC
$1.34B
| $791K | 0.01% |
+11,901
| New | +$774K |
|
503
Humana
HUM
$43.7B
| $787K | 0.01% |
6,980
+3,380
| +94% | +$352K |
|
|
RDC
504
DELISTED
Rowan Companies Plc
RDC
| $786K | 0.01% |
+23,315
| New | +$762K |
|
505
Coty
COTY
$2.42B
| $785K | 0.01% |
+52,390
| New | +$766K |
|
|
MM
506
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
| $783K | 0.01% |
+113,040
| New | +$798K |
|
507
Automatic Data Processing
ADP
$106B
| $775K | 0.01% |
11,422
+4,132
| +57% | +$281K |
|
|
NTUS
508
DELISTED
Natus Medical Inc
NTUS
| $774K | 0.01% |
+30,000
| New | +$756K |
|
|
BEAV
509
DELISTED
B/E Aerospace Inc
BEAV
| $773K | 0.01% |
12,291
+6,902
| +128% | +$418K |
|
510
BCE
BCE
$20.2B
| $764K | 0.01% |
+17,700
| New | +$753K |
|
|
WFT
511
DELISTED
Weatherford International plc
WFT
| $761K | 0.01% |
43,804
-27,196
| -38% | -$417K |
|
|
CNH
512
PUT
CNH Industrial
CNH
$12.7B
| $757K | 0.01% |
+75,604
| New | +$726K |
|
|
SCHW
513
Charles Schwab
SCHW
$183B
| $753K | 0.01% |
27,538
+19,680
| +250% | +$514K |
|
514
Kroger
KR
$35.4B
| $728K | 0.01% |
33,314
-70,734
| -68% | -$1.41M |
|
|
IM
515
DELISTED
Ingram Micro
IM
| $724K | 0.01% |
24,467
+15,340
| +168% | +$412K |
|
516
Yelp
YELP
$1.45B
| $722K | 0.01% |
9,374
-71,265
| -88% | -$6.02M |
|
|
SUNE
517
DELISTED
SUNEDISON, INC COM
SUNE
| $722K | 0.01% |
38,294
-1,706
| -4% | -$28.4K |
|
518
Kimberly-Clark
KMB
$36.3B
| $717K | 0.01% |
6,783
-8,253
| -55% | -$855K |
|
519
Cadence Design Systems
CDNS
$93.6B
| $705K | 0.01% |
+45,300
| New | +$672K |
|
|
B
520
Barrick Mining
B
$61.5B
| $691K | 0.01% |
+38,700
| New | +$748K |
|
521
VanEck Gold Miners ETF
GDX
$22.7B
| $685K | 0.01% |
+29,000
| New | +$712K |
|
522
Citigroup
C
$222B
| $673K | 0.01% |
14,138
-68,044
| -83% | -$3.39M |
|
|
DISCK
523
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $673K | 0.01% |
+17,452
| New | +$667K |
|
|
MONT
524
DELISTED
MONTAGE TECHNOLOGY GROUP LTD
MONT
| $671K | 0.01% |
+33,474
| New | +$653K |
|
|
ROC
525
DELISTED
ROCKWOOD HLDGS INC
ROC
| $668K | 0.01% |
8,968
+3,519
| +65% | +$259K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.